International Space Station Research Explores Large-Scale Stem Cell Production for Earth-Based Therapies
Expedition 74 astronauts aboard the International Space Station are continuing research efforts to manufacture large quantities of stem cells for therapies on Earth. Previous studies have focused on fine-tuning hardware that allows scientists to produce greater quantities of high-quality stem cells. Now, the InSPA-StemCellEX-H2 investigation is aiming to demonstrate large-scale production of blood stem cells.
Microgravity offers unique advantages for cell cultivation. In the absence of Earth's gravitational pull, cells tend to aggregate differently and can grow in three-dimensional structures that more closely resemble natural tissue. This can potentially yield higher-quality stem cells for therapeutic applications.
The research builds on earlier work that established the foundational hardware and protocols for stem cell production in space. Scientists are now working to scale these processes to produce clinically relevant quantities that could eventually be used in medical treatments for conditions including cancer and various diseases.